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Although Toll-like receptor 9 (TLR9) has been impli-
cated in cytokine and type I interferon (IFN) produc-
tion during malaria in humans and mice, the high
AT content of the Plasmodium falciparum genome
prompted us to examine the possibility that malarial
DNA triggered TLR9-independent pathways. Over
6000 ATTTTTAC (‘‘AT-rich’’) motifs are present in
the genome of P. falciparum, which we show here
potently induce type I IFNs. Parasite DNA, parasit-
ized erythrocytes and oligonucleotides containing
the AT-rich motif induce type I IFNs via a pathway
that did not involve the previously described sensors
TLR9, DAI, RNA polymerase-III or IFI16/p204. Rather,
AT-rich DNA sensing involved an unknown receptor
that coupled to the STING, TBK1 and IRF3-IRF7 sig-
naling pathway. Mice lacking IRF3, IRF7, the kinase
TBK1 or the type I IFN receptor were resistant to
otherwise lethal cerebral malaria. Collectively, these
observations implicate AT-rich DNA sensing via
STING, TBK1 and IRF3-IRF7 in P. falciparummalaria.
INTRODUCTION
Malaria is the world’s most common infectious disease,
affecting 250 million people annually with close to 1 million
deaths, mainly in children. Recurrent infections for individuals
living in endemic malarial regions are common because the
disease does not promote strong acquired immunity. While
a combination of vector control and therapy has eliminated
malaria from the wealthy countries of the world, vaccine devel-
opment remains a major goal for eradication of malaria in
underdeveloped countries. Much is known about the acquired194 Immunity 35, 194–207, August 26, 2011 ª2011 Elsevier Inc.immune responses to both the natural Plasmodium infec-
tion and a variety of immunogens (Clark et al., 2004). In con-
trast, little is known about the innate immune response during
malaria.
The life cycle of Plasmodium falciparum begins in the liver.
After initial replication, the parasite bursts from hepatocytes
and infects erythrocytes, where cycles of asexual replication
occur. The cyclic rupture of parasitized erythrocytes releases
one or more malarial components (‘‘malarial toxins’’) that acti-
vate phagocytes to drive inflammation resulting in systemic
symptoms including fever, headaches and rigors. The molecular
mechanisms involved in sensing malarial products are poorly
understood.
Much progress has been made in our understanding of how
phagocytes sense microbial products. The Toll-like receptor
(TLR) family has been linked to the recognition of protozoan
parasites (Gazzinelli et al., 2004). In humans, polymorphisms in
TLR2, TLR4, TLR9, and Mal (also known as TIRAP) have been
linked to the clinical outcome of malaria (Khor et al., 2007; Mock-
enhaupt et al., 2006). Plasmodium glycosylphosphatidylinositol
(GPI) anchors trigger TLR2 (Zhu et al., 2005); however, GPI
anchors alone cannot account for the immune stimulatory
activity of malaria (Wu et al., 2010). Infected erythrocytes contain
both the parasite and malaria-derived debris. During the intraer-
ythrocytic stage, parasites digest hemoglobin and produce an
inert, insoluble crystal, known as hemozoin, via a detoxification
process. Natural hemozoin is coated with both proteins and
plasmodial DNA and triggers TLR9 (Parroche et al., 2007; Wu
et al., 2010). The ability of hemozoin to activate TLR9 is probably
due to the delivery of plasmodial genomic DNA via hemozoin to
the endosomal compartment. Indeed, CpG-containing DNA
oligonucleotides designed from the actual sequences of malaria
genome signal via TLR9 (Parroche et al., 2007). Mice deficient in
MyD88 and Il1r-Il18r signaling have decreased production of
IL-12 and attenuated pathology during infection with murine
Plasmodium spp. (Adachi et al., 2001; Franklin et al., 2007;
Pichyangkul et al., 2004). Studies of cerebral malaria in mice
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experimental cerebral malaria (ECM), additional mechanisms
also contribute (Togbe et al., 2007).
Although polymorphisms in interferon-g (IFN-g) receptor loci
are well associated with malarial susceptibility (Koch et al.,
2002; Naka et al., 2009), evidence has also linked polymorphisms
in the type I IFN receptor (Ifnar1) (Aucan et al., 2003) to increased
survival. Type I IFNs are typically generated in response to nu-
cleic acids. Although plasmacytoid dendritic cells (pDCs) are
a major source during virus infections, many cell types produce
these cytokines. A number of reports have revealed the ability
of Plasmodium to induce type I IFNs (Aucan et al., 2003;
Pichyangkul et al., 2004; Viga´rio et al., 2007). In pDCs, TLR9
may regulate the IFN response to schizonts (Pichyangkul et al.,
2004). Several additional nucleic acid sensors have also been
implicated in IFN gene regulation; however, their role in malaria
has not been explored to date.
In this study, we investigated the role of TLR-independent
DNA sensors in type I IFN production during malaria. RNA
profiling of leukocytes from febrile patientswithP. falciparumma-
laria demonstrated elevated expression of interferon-inducible
genes (ISGs). Although the malaria genome contains several
hundred CpG motifs, and plasmodial DNA as well as schizonts
have been shown to activate TLR9 (Parroche et al., 2007;
Pichyangkul et al., 2004), the genome is 80% AT (Gardner
et al., 2002). In this report, we define a very commonAT-richmotif
in malaria, i.e., ATTTTTAC, which had previously been noted by
others to be proinflammatory when isolated from probiotic
bacteria (Shimosato et al., 2006). This motif is present over
6,000 times in P. falciparum and is also as commonly found in
P. vivax. We used the genome of P. falciparum to design
oligonucleotides (ODNs) that contain this AT-rich motif—these
ODNswere highly immune stimulatory in both human andmurine
cells. AT-rich DNA activated proinflammatory cytokines such
as TNF-a and IL-6 and also activated IFN-b gene transcription.
We found that AT-rich DNA induced type I IFNs via a pathway
that was independent of TLRs, DAI, RNA polymerase III, and
IFI16/p204 but dependent on stimulator of interferon genes
(STING) (Ishikawa and Barber, 2008; Zhong et al., 2008), Tank-
binding kinase 1 (TBK1) (Fitzgerald et al., 2003; Ishii et al.,
2008), and the interferon regulatory factors 3 (IRF3) and IRF7.
Moreover, Plasmodium-infected RBCs also triggered IFN in
macrophages via this STING-dependent pathway. Finally, mice
lacking Tbk1, Irf3, and Irf7 as well as the Ifnar1 were resistant to
lethal cerebral malaria. We suggest that this AT-rich DNA sen-
sing pathway is important in the innate immune response to
Plasmodial infection and determines the eventual outcome of
malarial infections.
RESULTS
P. falciparum Induces Interferon Stimulated Genes
during Malaria Infection
We performed global gene expression profiling of human
PBMCs harvested from smear-positive symptomatic patients
infected with P. falciparum (Pf), before and after curative treat-
ment with antimalarial drugs. Patients were sick with malaria
for 1–3 days (and incubating Pf for at least an additional week
prior to symptoms) and had either a documented fever at thetime of enrollment or a history of fever and/or rigors within
the 24 hr period proceeding initial study. We chose to study
the same patient before and after curative treatment, allowing
us to measure effects due to malaria that are not compounded
by other potential infections in non-malaria-infected individuals.
An analysis of >580 genes induced revealed the presence of
a number of ISGs, including Aim2, Oas1, Ifitm3, Card12, and
Ifitmp4 (Der et al., 1998; Sanda et al., 2006) (Figure 1A). To
determine the direct effect of Pf on type I IFNs, we stimulated
PBMCs with Pf-infected red blood cells (iRBCs). We found
a robust induction of IFN-b mRNA. As expected, uninfected
RBCs (uRBCs) did not induce IFN-b mRNA (Figure 1B).
IFN-a was also induced at the protein level by iRBCs (data not
shown).
We have previously demonstrated that natural hemozoin
presents plasmodial DNA to TLR9 (Parroche et al., 2007). We
therefore purified hemozoin and gDNA from Pf cultures and
examined their ability to induce IFN-b. Examination of the he-
mozoin by microscopy confirmed that it was free of contami-
nating iRBC or parasites (data not shown). Cultured hemozoin
induced substantial amounts of IFN-b (Figure 1C), the activity
of which was lost upon DNase treatment. Like hemozoin, puri-
fied Pf genomic DNA (gDNA) strongly stimulated IFN-b when
delivered to the cytosol of cells with cationic lipids (Figure 1C).
Imaging studies showed that the hemozoin crystal was phago-
cytosed by macrophages and was shortly thereafter found
within the lysosomal compartment (Figure 1D). At longer time
points, the crystal was found localized in the cytosol, showing
no lysotracker colocalization. This highlights a mechanism by
which hemozoin-associated cargo such as plasmodial DNA
might access the cytosol. PBMCs incubated with DNA alone
in the absence of lipofectamine failed to upregulate IFN-b
(data not shown). These data suggest that plasmodial geno-
mic DNA can drive IFNb upon access to the cytosolic
compartment.
Malarial AT-Rich DNA Activates Both NF-kB-
and IRF-Dependent Gene Transcription
The high AT-rich content of the malarial genome and the pres-
ence of the AT-rich motif, ATTTTTAC, found >6,000 times in
Plasmodium spp., prompted us to test whether this motif was
immunostimulatory. The motif is found in nearly the same
abundance in P. vivax, a species of Plasmodium that is not nearly
so AT rich (Table S1 available online). The motif is also found
in viruses, bacteria, and the human genome, albeit at lower
frequencies.
We designed ODNs that contained the AT-rich motif (20-mers)
with sequences derived from the malarial genome (Table S2).
Like Pf gDNA, all six of these AT-rich motifs activated the
IFN-b promoter in HEK293 cells (Figure 2A and Figure S1).
ODNs designed on the basis of a portion of the genome located
on Pf chromosome 9 containing three AT-r repeats were stimu-
latory in HEK293 cells or mouse macrophages (Figures 2A and
2B). Human PBMC, THP-1, mouse splenocytes, fibroblasts,
bone marrow-derived macrophages (BMDM), and splenic DCs
also induced IFN-bmRNA and protein in response to the AT-rich
ODN (Figures 2B–2I). AT-rich DNA also induced IFN-a (data not
shown) and NF-kB activation as well as cytokines like TNFa and
IL-6 (Figures 2J and 2K).Immunity 35, 194–207, August 26, 2011 ª2011 Elsevier Inc. 195
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Figure 1. P. falciparum Induced Interferon-
Stimulated Gene Expression in Human Cells
(A) A microarray analysis of PBMCs from
14 patients infected with Pf, before or after cura-
tive treatment with mefloquine. A selection of
ISGs from a cohort of 580 upregulated genes is
depicted.
(B) PBMCs were stimulated with Pf-infected red
blood cells (iRBCs), uninfected RBCs (RBCs) or
SeV (200HAU/ml) for 3 to 9 hr.
(C) PBMCs were stimulated with LPS (100ng/ml),
100 mM natural hemozoin (Hz) untreated or pre-
treated with S. aureusmicrococcal nuclease (Hz +
DNase) or 5 mg of genomic DNA (Pf gDNA) com-
plexed with lipofectamine 2000. IFN-b and b-actin
mRNA was measured by qPCR.
(D) Mouse BMDM were treated with 200 mM Hz
and Hz and lysosomes were visualized with
acousto-reflection microscopy and lysotracker,
respectively. Fields are representative of at least
ten fields of view and two independent experi-
ments.
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An AT-Rich DNA Sensing PathwaySecondary Structure Is a Critical Determinant
of AT-Rich ODN Stimulatory Activity
We next designed a series of ODNs in which the sequences
were modified (Figures S2A–S2C). Substituting the central TT
with AA, so that the motif was now ATTAATAC, had little effect
(Figure 3A and Figure S2A). In analyzing the active ODN using
the mFold algorithm, we realized that all of the active ODNs
had a stem-loop structure. Disruption of the stem-loop structure
substantially reduced their activity (Figure 3B and Figure S2C).
We also assessed whether single stranded-ness was a deter-
mining factor in the activity of the ODNs. When cells were
stimulated with double-stranded AT-rich ODNs, we continued
to see a robust activation of IFN-b. We also used the 45 bp
immunostimulatory DNA (ISD) derived from the Listeria genome,
which was annealed and prepared the same way as dsAT-rich
stem loop. Only ds but not ss ISD induced a robust activation196 Immunity 35, 194–207, August 26, 2011 ª2011 Elsevier Inc.of the IFN-b reporter (Figure 3C). Struc-
tural predictions suggested that the
AT-rich stem-loop DNA hybridized to
the reverse strand still had secondary
structure, which was not seen when ISD
was analyzed in a similar manner (Fig-
ure 3C). Collectively, these data indi-
cate that the secondary structure of the
AT-rODN is the critical determinant for
activity.
AT-Rich ODN Uses a Toll-like
Receptor-Independent Signaling
Pathway
The initial reports of AT-rich DNA ele-
ments in probiotic bacteria concluded
that their activity relied on TLR9 (Shimo-
sato et al., 2006). We have previously re-
ported that Pf gDNA can signal via TLR9
(Parroche et al., 2007). To define the role
of TLR9 in sensing AT-rich ODNs, wetook advantage of HEK293 cell lines that either expressed or
lacked TLR9. Because CpG-DNA does not trigger IFN-b in
HEK293-TLR9 cells, NFkB activation was monitored in this
case. Pf gDNA was transfected with lipofectamine 2000 or
DOTAP, which target DNA to the cytosol or endosome, respec-
tively. Pf gDNA (which contains both CpG and AT-rich stem-loop
DNA motifs) activated NFkB when delivered to the endosomal
compartment with DOTAP in TLR9-expressing HEK293 cells
but not in the parental HEK293 cell line (Figure S3). In contrast,
Pf gDNA activated NFkB in both cell lines when delivered via lip-
ofectamine (Figure S3). These data confirm that Pf gDNA can
engage TLR9, when delivered to the endosomal compartment,
but triggers an alternative response if delivered to the cytoplasm
(Figure S3).
We next tested the ability of AT-rich ODN sequences to trigger
IFNb in Tlr9/ cells. Pf gDNA and AT-r ODN delivered via
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Figure 2. Immune Stimulatory Activity of
AT-Rich Motifs from P. falciparum
(A) IFN-b reporter gene activity was measured in
cells stimulated with media alone () or purified
Pf g DNA (5 mg/ml), AT5 ODN (20-mer, 3 mM,
phosphorothiorate backbone [PS]), Pf chromo-
somal-derived Pf Chr 9_2 long ODNs (56-mer,
3mM, PS), and poly (dA-dT) (5 mg/ml) complexed
with lipofectamine 2000. Data are represented as
fold induction relative to the reporter-only control
and reflect mean fold induction ± SD.
(B) Bone marrow-derived macrophages (BMDMs)
were stimulated with AT-rich ODNs on phospho-
diester backbones (PD), SeV and pdAdT. IFN-b
secretion was measured 16 hr later by ELISA.
(C–I) HEK293, PBMCs, THP-1, mouse spleno-
cytes, embryonic fibroblasts (MEFs), BMDMs, and
splenic dendritic cells (panDCs) were stimulated
for 6 hr with 3 mM AT2/AT5 (PS) or AT5 (PD) and
IFN-b levels measured by qPCR.
(J) NF-kB reporter gene activity in HEK293
cells stimulated with AT2 (3 mM, PS), poly (dA-dT)
(5 mg/ml), or infected with SeV (200HAU/ml).
(K) IL-6 or TNFa levels were measured by ELISA
from macrophages treated as indicated for 18 hr.
Data are presented as mean ± SD and are repre-
sentative of three independent experiments.
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An AT-Rich DNA Sensing Pathwaylipofectamine induced normal levels of IFNb mRNA in spleens
from Tlr9/ mice (Figure 4A). Although CpG-containing ODNs
induced modest amounts of type I IFN, this activity was lost
in macrophages and splenocytes harvested from Tlr9/
mice (Figure 4A and data not shown). Myd88/Ticam1/
splenocytes and macrophages also responded normally to the
presence of cytosolically administered AT-rich ODNs and Pf
gDNA ruling out a role for any other TLRs (Figure 4B and data
not shown).Immunity 35, 194–207AT-Rich Stem-Loop DNA Does Not
Result in the Activation of Any
Known Nucleic Acid Sensor
A growing number of nucleotide recep-
tors have been identified which includes
retinoic inducible gene-I (RIG-I, encoded
by Ddx58), melanoma differentiation as-
sociated gene-5 (Mda-5, encoded by
Ifih1) (Kawai et al., 2005; Yoneyama
and Fujita, 2009), NOD2 (Sabbah et al.,
2009), and DNA-dependent activator of
IFN-regulatory factors (DAI, encoded by
Zbp1) (Takaoka et al., 2007). To examine
the role of these sensors, we tested
bone marrow cells that were deficient
in each of these receptors. Ifih1/,
Ddx58/, and Mavs/ responded nor-
mally to AT-rich stem-loop DNA (Figures
4C–4E). Similar results were observed
with Nod2/ and Zbp1/ cells (Figures
4F and 4G). The reduction of DAI
expression in HEK293 cells by RNAinterference also had no effect on AT-rich ODN activity
(Figure 4H).
AT-Rich Stem-Loop DNA Uses a Distinct Pathway
from B-Form Double Stranded Poly(dA-dT)
to Induce Type I IFNs
In human cells, poly(dA-dT) drives type I IFNs via RNA poly-
merase III, which converts poly(dA-dT) into a ligand for the
RIG-I-MAVS pathway (Ablasser et al., 2009; Chiu et al., 2009)., August 26, 2011 ª2011 Elsevier Inc. 197
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Figure 3. AT-Rich Motifs Induce IFN-b Production in a Sequence and Secondary Structure-Dependent Manner
(A) HEK293 cells transfected with the IFN-b reporter plasmid were stimulated with SeV, poly(dA-dT), and AT-rich ODNs that weremodified (*) as in Figure S2A and
luciferase activity was read an additional 24 hr later.
(B) Putative secondary structure of AT-rich ODN AT5, with AT-motif and probable chief base-base interactions highlighted. Key base-base interaction and
secondary structure was abolished by base-directed substitution of the original sequences as shown in Figure S2B. Splenocytes from C57BL/6 mice were
stimulated with the parent AT5 (3 mM, PD) and denoted base-substituted oligonucleotides and IFN-b mRNA induction measured by qPCR. NDV, NewCastle
Disease Virus.
(C) Predicted secondary structure of annealed AT5 and reverse strand and ISD (3 mM each, PD). BMDMs from C57BL/6 mice were stimulated with the single
stranded (ss) AT5, AT5 annealed to its reverse strand (AT5 + R), annealed ISD, and ssISD (forward strand only) for 18 hr and IFN-b secretion was measured by
ELISA. Data are presented as mean ± SD and are representative of three independent experiments.
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Figure 4. AT-Rich DNA Mediated IFN-b
Induction DoesNot Require TLRs, Cytosolic
Sensors, or the Adaptor Protein MAVS
(A and B) Splenocytes from the indicated strains
were stimulated with CpG-B 1826 (5 mM), AT5
(3 mM, PD), or Pf gDNA (100 ng/ml) complexed
with lipofectamine 2000 for 6 hr, and IFN-b was
measured by qPCR and/or ELISA.
(C–G) BMDMs from the indicated strains were
stimulated with lipofectamine complexed AT5
(3 mM, PD), poly (dA-dT) (5 mg/ml), and poly (I:C)
(100ng/ml) or infected with SeV (200 HAU/ml), and
IFN-b mRNA measured by qPCR or ELISA.
(H) HEK293 cells were transduced with two
lentiviruses encoding shRNA for DAI, and IFN-b
reporter gene activity was measured from cells
stimulated with lipofectamine complexed-AT2
(3 mM, PS) or infected with NDV (80HAU/ml)
for 24 hr. The efficiency of DAI silencing was
examined by RT-PCR. Data are presented as
mean ± SD and are representative of three inde-
pendent experiments.
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An AT-Rich DNA Sensing PathwayThis pathway is redundant with additional sensors in mouse
macrophages. To test this pathway, we silenced RIG-I, MAVS,
and RNA polymerase III component 1 (RPC1) by RNAi in
HEK293 cells and measured IFN-b reporter gene activity.
siRNA-mediated silencing of these components had no effect
on the ability of AT-rich stem-loop DNA to induce IFN-b gene
transcription (Figure 5A and Figure S4A). siRNA-mediated
silencing of these components had no effect on the ability of
AT-rich stem-loop DNA to induce IFN-b gene transcription. We
also tested whether transfected AT-rich ODNs would result in
the RNA pol III-dependent production of stimulatory RNA. RNAImmunity 35, 194–207extracted from transfected 293 cells
was tested for its ability to activate RIG-I
in PBMCs. Although IFN-a was induced
with small and total RNA from the pol-
y(dA-dT) transfected cells, Plasmodial
AT-rich stem-loop DNA did not yield
a stimulatory RNA species (Figure 5B).
Similarly, HEK293 cells were able to
induce the activation of the IFN-b reporter
in response to RNA extracted from pol-
y(dA-dT) transfected but not in response
to AT-rich stem-loop DNA-derived RNA
(Figure S4B).
We also tested ML-60218, an inhibitor
of RNA pol III (Ablasser et al., 2009;
Chiu et al., 2009), and NS3/4A (a pro-
tease component of the Hepatitis C virus
that blocks RIG-I signaling (Foy et al.,
2005; Meylan et al., 2005), neither of
which had any effect on AT-rich ODN-
induced activation (Figures 5C and 5D).
Finally, Zbp1-deficient macrophages
treated with the RNA pol III inhibitor
ML60218 (Figure 5E) responded normally
to AT-rich ODNs, excluding the possi-bility that DAI and RNA pol III function redundantly. We
confirmed these findings in HEK293 cells transfected with
DAI-specific shRNA pretreated with ML60218 (Figure 5F).
Recently, IFI16 was identified as a sensor of viral DNA that
couples to the STING pathway (Unterholzner et al., 2010).
siRNA-mediated transient knockdown of Ifi204/p204 (the
murine ortholog of IFI16) prevented HSV and VACV DNA driven
IFN-b induction (Figure 5G) but had no effect on AT-r stem-loop
DNA (Figure 5G). Collectively, these data suggest that AT-r DNA
induce IFN-b independently of all currently described DNA
sensing receptors., August 26, 2011 ª2011 Elsevier Inc. 199
AE
0
5
10
15
20
25
poly (dA-dT)SeV(-)
0
2
4
6
8
NS3/4A
NS3/4A S139A
AT2 ODN(-)
HEK-293
IF
N
β l
uc
ife
ra
se
 (fo
ld 
ind
uc
tio
n)
C
D
0
50
25
HEK-293 +RNA Pol III inhibitor
IF
Nβ
 
lu
cif
er
as
e 
(fo
ld 
ind
uc
tio
n)
0
100
200
300
400
500
small RNA total RNA
PBMC
hI
FN
α
 
IU
/m
L
AT
2-O
DN
po
ly 
(dA
-dT
)
AT
2-O
DNSe
V
ATR-ODN 293T
PBMCs
(-) (-) (-)
9h
18h
TLR3+ HEK293
0
200
400
600
800
IF
Nβ
/β-
ac
tin
 (A
.U
)
No
 si
RN
A
No
 si
RN
A
co
ntr
ol 
co
ntr
ol 
MA
VS
MA
VS
RI
G-
I
RI
G-
I
RP
C-
1
RP
C-
1
AT2-ODN
(-)
0
2000
4000
6000
8000
No
 si
RN
A
co
ntr
ol 
MA
VS
RI
G-
I
RP
C-
1
poly (dA-dT)
SeV
IF
Nβ
/β-
ac
tin
 (A
.U
)
po
ly 
(dA
-dT
)
DMSO poly(dA-dT) AT-r ODN
(-) TE AT5
 
pd
Ad
T
Pf 
gD
NA Se
V
0
100
200
300
400
500
0uM
6.25uM
12.5uM
25uM
I
F
N
 
I
U
/
m
l
(-) TE AT5
 
pd
Ad
T
Pf 
gD
NA Se
V
0
100
200
300
400
500
0uM
6.25uM
12.5uM
25uM
C57Bl/6 macrophages + RNA Pol III Inhibitor DAI-/- macrophages + RNA Pol III Inhibitor
(-) pdAdT AT2 SeV
0
5
10
15
20
25
100ng shDAI1
100ng shDAI2
100ng shDAI 1 + 25uM Pol III
100ng shDAI 2 + 25uM Pol III
F G
IF
N
β l
uc
ife
ra
se
 (fo
ld 
ind
uc
tio
n) HEK-293 +RNA Pol III inhibitor
100ng shDAI #1 100ng shDAI #2
(-) pdA
dT
AT
2
Se
V (-) pdA
dT
AT
2
Se
V
NS (65kDa)
DAI (46kDa)
B
Macrophages
siControl
No siRNA
(-)
VA
CV
 
70
me
r
HS
V 
60
m
er
AT
5
Se
V
0
1000
2000
3000
6000
8000
10000
12000
14000
16000
I
F
N
 
I
U
/
m
l
(-) VA
CV
 
70
me
r
HS
V 
60
me
r
AT
5
Se
V (-) VA
CV
 70
me
r
HS
V 
60
m
er
AT
5
Se
V
siControl
β-actin (45kDa)
Figure 5. P. falciparum AT-Rich Motifs Do
Not Signal via RNA-Polymerase III/RIG-I
(A) RIG-I, MAVS, and RNA polymerase III compo-
nent 1 (RPC1) were silenced by RNAi. Forty-eight
hours later, cells were stimulated with AT2 (PS; left
side of graphic), poly (dA-dT), and SeV (right side of
graphic). IFN-b gene induction was assessed 24 hr
later with qPCR.
(B) HEK293 cells were transfected with either poly
(dA-dT) or AT2 and RNA from the transfected cells
was harvested 16 hr later. Harvested RNA was
fractionated as indicated and transfected back into
PBMCs and IFN-a production assessed 9 or 18 hr
later.
(C) HEK293 cells were pretreated with 0, 2.5, 5, 10,
20, or 30 ng of the RNA polymerase III inhibitor, ML-
60218, or vehicle alone (DMSO) for 2 hr and IFN-b
reporter activity was measured after AT2 (PS) or
poly (dA-dT) treatment.
(D) A total of 0, 20, 40, 60, and 80 ng of plasmids
encoding the hepatitis C virus (HCV) protease NS3/
4A and the inactive mutant NS3/4A S139A were
transfected into HEK293 cells along with the IFN-b
reporter. Twenty-four hours later, the cells were
stimulated with AT2 (PS), poly (dA-dT) and SeV.
Luciferase activity was assessed an additional
24 hr later.
(E) C57Bl6 or Zbp1/ macrophages were pre-
treated with ML-60218 for 2 hr and then stimulated
as indicated, and IFN-b levels were measured by
ELISA.
(F) DAI was silenced by RNAi and cells pretreated
with the ML60218 inhibitor. IFN-b reporter gene
activity measured after cells were stimulated with
AT2, poly(dA-dT), and Sendai virus (SEV). shRNA-
mediated knockdown of DAI (Zbp1) was assessed
with immunoblotting at 48 hr after transfection of
shRNAs.
(G) Mouse macrophages were electroporated with
siRNA to Ifi204 or scrambled siRNA control for 48 hr
and then stimulated with indicated ligands for an
additional 24 hr. Supernatants were assessed for
levels of IFN-b (top) by ELISA, whereas lysates of
cells were assessed for levels of Ifi204 remaining
(bottom) by immunoblotting. Data are presented as
mean ± SD and are representative of three inde-
pendent experiments.
Immunity
An AT-Rich DNA Sensing PathwayIFN Induction by AT-Rich Stem-Loop DNA Requires
STING, TBK1, and IRF3/7
Most cytosolic DNA-induced IFN signaling pathways converge
on STING (encoded by Tmem173) (Ishikawa and Barber,200 Immunity 35, 194–207, August 26, 2011 ª2011 Elsevier Inc.2008; Ishikawa et al., 2009; Saitoh et al.,
2009) and TBK1 (Fitzgerald et al., 2003;
Ishii et al., 2008). Tmem173/ cells
were unable to induce IFN-b in response
to AT-rich stem-loop DNA or Pf gDNA
stimulation (Figure 6A). These findings
were corroborated with IFN-b reporter
assays in HEK293 cells transfected with
STING siRNA (Figure 6B). STING defi-
ciency also impairs the induction of a
number of additional ISGs as well asNF-kB dependent cytokines such as TNF-a, IL-6, and IL-15
upon treatment with either AT-rich ODNs or Pf genomic DNA
(Figure 6C and Figure S6). Although Tbk1/ mice die during
embryogenesis, this lethality is rescued by crossing these
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Figure 6. AT-Rich DNA-Mediated IFN-b
Induction Uses the Adaptor STING, TBK1,
and the Interferon Regulatory Factors IRF3
and IRF7
(A) BMDM from Tmem173/ mice were trans-
fected with lipofectamine complexed AT5 (3 mM,
PD), Pf gDNA (100ng/ml) and poly (dA-dT) (3.5 mg/
ml) or infected with SeV (200HAU/ml), and IFN-b
gene induction was measured 6 hr later by qPCR.
(B) STING was silenced by siRNA and IFN-b
reporter gene activity was measured after treat-
ment with poly (dA-dT) and AT2.
(C) BMDMs from Tmem173+/+ and Tmem173/
mice were stimulated as indicated for 6 hr and
gene expression was analyzed with Nano-string
technology. Key genes affected are shown.
(D) Tbk1/Tnfr1/ and Tnfr1/ BMDMs were
treated as indicated and IFN-b mRNA levels were
measured by qPCR.
(E) HEK293 cells (upper panels) or BMDMs
from Tnfr1/, Tbk1/Tnfr1/, Tmem173+/+ and
Tmem173/ mice were transfected as indicated
with biotinylated ODNs. Cell lysates were sub-
jected to pull-down analysis, and immunoblots
were probed for the presence of STING and TBK1
by immunoblotting.
(F) HEK293 cells were transfected with multi-
merized PRDIII-I and PRDII reporter elements from
the IFN-b promoter and stimulated as above.
Luciferase reporter activity was measured.
(G–I) BMDMs from Irf3/Irf7/, Irf3/, and
Irf7/ mice were transfected as indicated and
levels of IFN-b mRNA were quantified 6 hr later
by qPCR.
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An AT-Rich DNA Sensing Pathwaymice to the Tnfr1/ mice (Bonnard et al., 2000). We therefore
also compared Tnfr1/ and Tbk1/Tnfr1/splenocytes and
BMDMs for AT-rich ODN-induced IFN-b gene transcription
and secretion. Tbk1/Tnfr1/ splenocytes had a markedly
reduced IFN-b response upon challenge with AT-rich ODNs
(Figure 6D).
We also tagged AT-2 or AT-5 ODNs with biotin and performed
streptavidin pull-down assays in lysates from HEK293 cells to
examine STING-TBK1 complex formation. The labeled ODNs
precipitated the STING-TBK1 complex, whereas a control non-
stimulatory ODN, in which the DNA sequences were scrambled,
failed to immunoprecipitate this complex (Figure 6E). The immu-
noprecipitation of STING appears to be dependent on TBK1
given that AT-rich ODNs precipitated STING in macrophage
lysates from Tnfr1/ mice but failed to pull down STING from
lysates of Tbk1/Tnfr1/ mice. Moreover, TBK1 was brought
down in a complex with the AT-rich ODNs in Tmem173+/+
macrophages but failed to do so in Tmem173/ macrophages.
Thus, STING and TBK1 cooperatively associate in this AT-rich
stem-loop DNA sensing pathway. There is a partial role for the
TBK-1-related kinase IKKε in AT-rich stem-loop DNA-dependent
IFN-b production (Figure S5A).
The transcriptional enhancer of the IFNb gene contains bind-
ing sites for NF-kB: the IRFs (IRF3 and IRF7) and the heterodi-
meric complex ATF-2/c-Jun (Panne et al., 2007). AT-rich ODNs
induced reporter gene expression from both the full-length
promoter and from reporter genes driven by multimerized
individual promoter elements (Figure 6F and data not shown).
Activation of IRF3-IRF7 has been considered a defining event in
the transcriptional regulation of the IFN-b gene (Honda and
Taniguchi, 2006). IFN-b inductionwasseverely abrogated in sple-
nocytes from Irf3/Irf7/ double knockout (DKO) mice well as
from the single KOs after treatment with AT-rich ODNs (Figures
6G–6I). This result suggests that AT-rich stem-loop DNA from
Plasmodium most likely activates type I IFN induction via IRF3
and IRF7 heterodimers. IRF1 and IRF5 were dispensable for
AT-rich ODN-mediated IFN-b induction (Figures S5B and S5C).
To examine the physiological relevance of this pathway to
malaria infection, we conducted a series of ex vivo experiments
in which parasitized RBCs (P. berghei ANKA-infected RBCs
[PbA iRBCs] or Pf iRBCs) were incubated with mouse macro-
phages from either wild-type mice or mice deficient in key
components of the cytosolic AT-rich pathway identified above.
Macrophages from Irf3/Irf7/ or Tbk1/Tnfr1/ mice failed
to induce IFN-b in response to purified Pf iRBCs. A similar defect
was seen when PbA iRBCs were introduced to Tbk1/Tnfr1/
or Irf3/Irf7/ cells (Figures 7B and 7C). We also compared
wild-type and Tmem173/ cells and as seen in Figure 7D,
STING-deficiency led to a partial but significant defect in type I
IFN responses in response to PbA iRBCs.
TBK1-IRF Dependent Type I Interferon Pathway
Is Central to the Pathogenesis of Experimental
Cerebral Malaria
We next wanted to test whether this pathway was important in
plasmodial infection in vivo. P. berghei ANKA (PbA) causes
cerebral malarial disease in mice. The model reflects many of
the signs of human cerebral malaria, including lethargy, limb
paresis-paralysis, vestibular dysfunction, coma, and death, and202 Immunity 35, 194–207, August 26, 2011 ª2011 Elsevier Inc.is a useful model for assessing the contribution of host factors
in the pathogenesis of severe malaria (Neill and Hunt, 1992).
Susceptible strains of mice, when infected with blood stage
forms of P. berghei ANKA, rapidly develop parasitemia and cere-
bral symptoms and typically die within 7–12 days. As seen from
our initial analysis of the PbA genome (Table S1), much like
P. falciparum, PbA is very AT rich (76%), with a large number of
AT-rich motifs (5266). In order to define the role of type I IFNs
in this model, we infected wild-type mice and Ifnar1/ mice
with 1 3 105 parasites of the PbA. Parasite loads, survival, and
development of neurological symptoms typically associated
with cerebral progression were monitored over a 22 day period.
No differences in parasitemia were observed in the two strains
of mice up to the time of death (data not shown). Of the 27 wild-
type animals infected, all were dead by day 12; in all but one of
these animals, we observed gross neurological abnormalities.
In contrast, of the 22 Ifnar1/ mice tested, all but one survived.
(Figure 7E). This difference in outcome was highly statistically
significant (p < 0.0001). Furthermore, PbA infections in
Irf3/Irf7/ mice also revealed that these transcription factors
are necessary for the progression of cerebral malaria in mouse
models, given that mice deficient for these factors survived
longer than the wild-type mice (Figure 7F). Similar observations
were made when TBK1 hypomorphic mice (Tbk1D/D), as
described previously (Marchlik et al., 2010), were used (Fig-
ure 7G). These data indicate that the TBK1-IRF3-IRF7 dependent
production of type I IFN and subsequent IFN signaling play an
important role in the pathogenesis of cerebral malaria.
DISCUSSION
As all organisms are defined by their nucleic acids, it should not
be surprising that nucleic acids have emerged as key triggers of
innate immunity. In this report, we have identified a DNA sensing
pathway important in innate immunity to malaria. This pathway
does not involve any of the known DNA receptors described to
date but otherwise follows a core STING-TBK1-IRF signaling
pathway. Plasmodial DNA activates this AT-rich stem-loop
DNA sensing pathway either as single stranded or double
stranded in a sequence-specific manner.
It is probable that AT-rich stem-loop DNA only activates this
STING-dependent pathway when it finds its way into the cytosol.
Experimentally, this was achieved with a transfection reagent
such as lipofectamine. Our previously published findings, that
plasmodial DNA signals in DCs via TLR9, were explored with
DOTAP (Parroche et al., 2007), a transfection reagent that pref-
erentially targets DNA to the endolysosomal compartment. In
the absence of transfection reagents, a key question is how
DNA could gain access to cytosolic sensors during an actual
infection. We propose that hemozoin acts as a vehicle to deliver
DNA to a subcellular compartment in which it can have biological
effects. This may be particularly relevant because during
Plasmodium infections, concentrations achieved by free hemo-
zoin in the blood approach 0.2–1mg/ml (Ha¨nscheid et al.,
2007). Upon uptake into an immune cell, hemozoin traffics to
the phagolysosomal compartment, and TLR9 appears to gain
access there to the CpG motifs on the crystalline surface (Par-
roche et al., 2007). The hemozoin crystal itself activates the cyto-
solic NLRP3 inflammasome (Dostert et al., 2009; Griffith et al.,
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Figure 7. Role of STING, TBK1, and the Transcription Factors IRF3-IRF7 in Plasmodium-Induced IFN Responses In Vitro and In Vivo
(A) Pf -infected RBCs (iRBCs) or uninfected RBCs (uRBCs) were incubated with C57Bl/6, Irf3/Irf7/, Tbk1/Tnfr1/, and Tnfr1/ BMDMs as indicated.
(B–D) Plasmodium berghei ANKA (PbA) iRBCs were incubated with BMDMs from Irf3/Irf7/, Tbk1/Tnfr1/, Tnfr1/ and Tmem173/ mice for 48 hr and
IFN-b induction was measured by ELISA.
(E–G) C57BL/6 (n = 15), Ifnar/ (n = 10), Irf3/Irf7/ (n = 7), Irf3+/+Irf7+/+ (n = 8), Tbk1+/+ (n = 5), and Tbk1D/D (n = 5) mice were infected i.p. with 105 parasites of
P. berghei ANKA strain and mice were monitored daily for survival as shown. (***p% 0.0001, Student’s t test). A representative of three independent experiments
is shown ± SD.
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An AT-Rich DNA Sensing Pathway2009; Shio et al., 2009). One of themechanisms by which NLRP3
is activated by crystals such as hemozoin, silica, and uric acid is
a result of their ability to destabilize the phagolysosome, which
allows the delivery of phagosomal contents, including cathep-
sins, to the cytosol (Halle et al., 2008; Hornung et al., 2008).
Phagosomal destabilization probably delivers the AT-rich
stem-loop DNA into the cytosol, in which it could then interact
with its cytosolic sensor. Indeed, we have observed that hemo-
zoin causes phagolysosomal instability and allows the contents
of this compartment, such as the hemozoin crystal and poten-
tially P. falciparum DNA on its crystalline surface, access to the
cytosol. These observations suggest that after the uptake of
DNA-coated hemozoin, sequential activation of a TLR9-depen-dent response in the phagolysosome and a TLR9-independent
response in the cytosol are likely to occur. This observation is
supported by the fact that components of both the TLR9
pathway (namely MyD88) as well as those of the STING-depen-
dent DNA response contribute to the IFN response to parasite-
laden RBCs. Whereas the defect in Tmem173-deficient cells
was incomplete, we found a complete defect in type I IFN induc-
tion in Tbk1/ and Irf3/Irf7/macrophages. Moreover, in line
with its previous role in conferring TLR-independent sensitivity to
DNA vaccines (Ishii et al., 2008), TBK1 is critical in the develop-
ment of ECM, probably through the induction of TLR-indepen-
dent pathways. Thus, our study suggests that two innate path-
ways are initiated during malaria: a TLR9- and a STING-drivenImmunity 35, 194–207, August 26, 2011 ª2011 Elsevier Inc. 203
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An AT-Rich DNA Sensing Pathwaypathway, both of which converge on the IRFs to regulate IFN
gene transcription.
A number of reports have revealed the ability of Plasmodium
spp to induce type I IFNs and a type I IFN gene signature (Aucan
et al., 2003; Pichyangkul et al., 2004; Viga´rio et al., 2007; Voisine
et al., 2010). Previous reports have shown that exogenous re-
combinant IFN-a can even inhibit ECM and reduce parasite
burden in mice infected with P. berghei ANKA (PbA) (Viga´rio
et al., 2007), although this effect requires pretreatment and is
reminiscent of the ability of LPS, for example, to prevent
Gram-negative sepsis in mice.
Although, pDCs are typically considered major sources of
IFN-a during microbial infections, recent studies indicate that
pDCs are not important in regulating immunity to P. chaubadi
and PbA infections (deWalick et al., 2007; Voisine et al., 2010).
In the case of P. chaubadi, this observation is not surprising
because these mice also do not benefit from the loss of the
type I IFN receptor (Voisine et al., 2010), but in mice infected
with PbA, this is a surprise, given the central role pDCs have in
generating type I IFNs. Thus, alternative sources of IFN-b,
probably mediated by cells other than pDCs via the cytosolic
AT-rich ODN pathway, may account for the apparent pathology
mediated by the type I IFNs in cerebral malaria, thus explaining
the lack of importance of pDCs in ECM models and perhaps in
human cerebral malaria.
The importance of DNA recognition and type I interferon
production is only now beginning to be appreciated in a large
spectrum of infectious illnesses well beyond the traditional role
of IFN-a/b in antiviral immunity. The data in this paper are
suggestive that plasmodial DNA has the capability of generating
type I IFN (as well as proinflammatory cytokines), which in turn
determine the outcome of disease. This view of the pathophysi-
ology ofmalaria is in agreement with the effect of polymorphisms
in the human IFN receptors on clinical infections (Aucan et al.,
2003; Koch et al., 2002; Naka et al., 2009) as well as by our
observation that patients withmalaria express a panoply of inter-
feron-stimulated genes. A further observation is that by our anal-
ysis, P. vivax, although seldom fatal, has a preponderance of
both AT motifs (5500) as well as CpG motifs (3000) (data
not shown). In contrast, Pf, most often associated with fatal ma-
laria, has a rather large number of AT motifs (6000) but much
smaller numbers of CpG motifs (300) (data not shown). The
importance of this distribution is not immediately clear and
may further shift our perception of DNA as a pathogen-associ-
ated molecular pattern (PAMP) useful in resolving disease.
In view of these results, as well as the emerging literature on
DNA sensing, we predict that immune recognition of DNA will
be an increasingly common theme in pathogenesis. Microbes
as diverse as Listeria monocytogenes (O’Connell et al., 2004;
Rayamajhi et al., 2010), Staphylococcus aureus (Martin et al.,
2009), Group B streptococcus (Streptococcus agalactiae)
(Charrel-Dennis et al., 2008) (Xiao et al., 2009) and Trypanosoma
cruzi (Chessler et al., 2008) all seem to induce significant amounts
of type I IFN through nucleotide recognition. This then suggests
that any immunomodulatory therapy contemplated for use as
an adjunct for any infectious disease will need to take into
account the role of DNA-induced type I IFN in a specific disease
and whether or not type I IFNs promote a healthy outcome or
enhance pathogenesis.204 Immunity 35, 194–207, August 26, 2011 ª2011 Elsevier Inc.EXPERIMENTAL PROCEDURES
Mice
Tlr9/, Myd88/, and Ticam1/ mice (gift of S. Akira, Osaka, Japan) were
used for generating Myd88/-Ticam1/ mice. Dai/ and Irf3/-Irf7/
mice were generated from Irf3/ and Irf7/ (gift of T. Taniguchi, Tokyo,
Japan). Tbk1/+ mice from W.C. Yeh (University of Toronto, Ontario, Canada)
were bred with Tnfr1/ mice for generating a double KO. TBK1D/Dmice were
from Pfizer Pharmaceuticals (MA) (Marchlik et al., 2010). Ddx58/ mice were
from S. Akira. Ifih1/ mice were from M. Colonna (Washington University, St.
Louis, MI). Mavs/ mice were from of Z.J. Chen (South Western Medical
School, Dallas, TX), whereas Tmem173/ mice were from G. Barber.
C57BL/6, Irf1/< and Irf5/ mice were from Jackson Laboratories (Bar
Harbor, ME). Ikkε/-deficient mice were from Millenium Pharmaceuticals
(Cambridge, MA). All mouse strains were bred and maintained under specific
pathogen-free conditions in the animal facilities at the UMass Medical School
in accordance with the Institutional Animal Care and Use Committee.
Reagents
CpG 2007 and 1826 were from Coley Pharmaceuticals, (Wellesley, MA).
DOTAP was from Roche (Indianapolis, IN) and Lipofectamine 2000 was from
Invitrogen (Carlsbad, CA). Poly(dAdT),Poly(dAdT) and poly(I:C) were from
Sigma-Aldrich and Imigenex, respectively. Lysotracker was from Molecular
Probes or Invitrogen (Carlsbad, CA). Forward and reverse strands of interferon
stimulating DNA (Stetson and Medzhitov, 2006) were obtained from IDT
(Coralville, IA). Pf 3D7 gDNA was obtained from the malaria research and
reference reagent resource center (MR4) at NIAID. Human embryonic kidney
293 cells were obtained from ATCC (Manassas, VA). ML60218 was from
Calbiochem.
Cell Culture, Stimulation, and Microscopy
Mouse bone marrow-derived macrophages, human PBMCs, primary cells,
HEK293, and THP-1s were cultured as described (Hornung et al., 2009; Rathi-
nam et al., 2010). Splenocytes and pan-DC subpopulations were isolated from
spleens as described (Goutagny et al., 2010). For stimulations, poly(dA-dT)
(1 mg/ml), ISD (3 mM), and AT-r stem-loop DNA (3 mM) were transfected
with lipofectamine 2000 in accordance with the manufacturer’s instructions.
Newcastle Disease Virus (NDV, LaSota strain) was obtained from P. Pitha
(Johns Hopkins, Baltimore, MD). Sendai Virus (SeV, Cantrell strain) was from
Charles River Laboratories (Wilmington, MA). A total of 1 3 105 macrophages
were plated with indicated numbers of Pf- or PbA-infected RBCs or uninfected
RBCs for 48 hr. For immunofluoresence 5 3 105 macrophages in a confocal
dish were stimulated with 200 mMnatural hemozoin for 1 and 6 hr. Lysotracker
(Molecular Probes or Invitrogen) was added to cells at a final dilution of
1:10000 in media for 15 min for visualization of the lysosomes. Specifically
hemozoin in cells was visualized with acousto-reflection microscopy with
a Leica SP2 microscope as described (Hornung et al., 2008).
RNA Extraction and Real-Time PCR
Human PBMC, mouse BMDM, HEK293, or mouse splenocytes (3 to 10 3 106
cells/condition), were stimulated for 6 to 17 hr with hemozoin (100 mM)
or poly(dA-dT) (5 mg/ml), CpG motifs (5 mM), AT-rich ODNs (3 mM), or
Pf gDNA (5 mg), all of which were transfected with lipofectamine 2000 (Invitro-
gen). RNA was extracted with RNeasy kit (QIAGEN, CA), cDNA was synthe-
sized, and quantitative RT-PCR analysis was performed with primers as
described (Charrel-Dennis et al., 2008; Goutagny et al., 2010). Gene expres-
sion data are presented as a ratio of gene copy number per 100 copies of
Actin ± SD.
P. falciparum Culture
Erythrocytic stages of Pf 3D7 isolates were cultured and natural hemozoin
and DNA from Pf were purified as described (Parroche et al., 2007). For
iRBC preparation, malaria cultures were synchronized with sorbitol for 3
cycles. Pf culture stage and parasitemia was assessed daily by field staining.
Where indicated, Pf enriched cultures at 8% parasitemia and trophozoite or
schizont stages were purified as described (Baratin et al., 2005; Cooper
et al., 2005; Wu et al., 2010). The culture was then adjusted to a parasitemia
of 8% and used for stimulating PBMCs at 40% hematocrit.
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The P. berghei ANKA (Pba) strain (gift of A. Luster, Harvard, Boston, MA)
was maintained by passage in C57BL/6 mice. Mice were inoculated i.p. with
1 3 105 infected RBCs and neurological symptoms and death were recorded
daily. Cerebral malaria was diagnosed by clinical signs including ataxia,
paralysis, deviation of the head, convulsions, and coma, followed by death.
Moribund animals were scored as dead and euthanized. For ex vivo infections
with PbA iRBCs, BALB/c mice were injected with PbA at 1 3 105 iRBCs and
parasitemia was monitored daily. Blood was collected by cardiac puncture
at 65% parasitemia.
Design of P. falciparum AT Motifs and Secondary Structure
Modeling
Twenty-mer AT ODNs containing the consensus motif 50-NNNNNNATTTTT
ACNNNNNN-30 were identified in the Pf genome using Fuzznuc, an algorithm
from the EMBOSS package (http://emboss.sourceforge.net/apps/release/6.
2/emboss/apps/fuzznuc.html). The Fuzznuc reverse option was enabled so
that both DNA strands were screened. All AT-rich ODNs, including biotin-
labeled ODNs, were synthesized by IDT (San Jose, CA) and tested on both
phosphodiester (PD) and phosphorothiorate (PS) backbones in different cell
types. All AT-rich stem-loop DNA sequences were uploaded on mFold
(M. Zuker) and secondary structure modeling was carried out at 37C and
default [Mg2+].
Microarray Analysis
Human studies were approved by the University of Massachusetts Medical
School Institutional Review Board, the local IRBs of the Brazilian institutions
and the Brazilian national IRB (CONEP approval number 10567). Portions of
the microarray analysis have been previously reported (Franklin et al., 2009)
where the methodology is reported in detail. The current study represents
14 otherwise healthy patients (from Porto Vehlo, Brazil) who were naturally in-
fected with P. falciparum before and 3–5 weeks after documented curative
treatment with mefloquine. Each patient served as his/her own control. PCR
was used for excluding patients with mixed infections involving P. vivax.
Simple filtering, normalization and averaging were carried out with BASE
(Bio-Array Software Environment) (https://base.mgh.har vard.edu/) and log
transformed (log2). Genes were filtered to include only genes with a signal
greater than the average signal from the negative controls in at least one of
the samples with a detection p value less than 0.0,1. Differences in gene
expression between the two conditions were considered significant if
p < 0.01 with a paired t test with Benjamini-Hochberg correction for multiple
testing and a fold change greater than 1.7.
ELISA
Cell culture supernatants were assayed for huIFN-a by ELISA (R&D or Bender
MedSystems), in accordance with the manufacturer’s instructions. The mouse
TNF-a and IL-6 kits were from eBiosciences, whereas themurine IFN-b kit is as
described (Roberts et al., 2007).
Reporter Assays
HEK293 cells (23 104 cells/well), were plated in 96 well plates and stimulated
for 24 hr as outlined above, and IFN-b, PRDIII-I, PPRD-II, PRD-IV, and NF-kB
luciferase reporter activity were measured as described (Rothenfusser et al.,
2005). The full-length IFN-b promoter and PRDIII-I, PRDII, and PRDIV lucif-
erase reporters were from T. Maniatis (Harvard University, Boston, MA).
pGL4-TK Renilla luciferase and pGL3-control luciferase were from Promega
(Madison, WI). pME18-NS3/4A-myc and NS3/4S139A-myc were from Z.J.
Chen (UT Southwestern, Dallas, Texas). The pGL3-enhancer-ELAM-minimal
promoter was used for assessing NF-kB activity.
RNA Preparation and Nanostring Experiment
If not indicated otherwise, DNA-transfected or SeV-infected 293 cells (2.4 3
105 cells per 12 wells) were collected 9 hr or 18 hr after stimulation. The Mini
RNA Isolation II Kit (Zymo Research) was used for RNA isolation with the
previously described modifications (Ablasser et al., 2009). nCounter CodeSets
were constructed for detecting selected mouse-specific genes as described
previously (Dixit et al., 2010). A total of 2 3 105 BMDMs from Tmem173+/+
and Tmem173/ animals were lysed in RLT buffer (QIAGEN) supplementedwith b-mercaptoethanol. Five percent of this lysate (containing 104 cells)
was hybridized to the Codeset for 16 hr and loaded onto the nCounter prep
station, and then quantified with the nCounter Digital Analyzer. For side-by-
side comparisons of nCounter experiments, data was normalized in two
ways described previously (Dixit et al., 2010).
RNA-Mediated Interference
First, siRNA was reverse-transfected at a concentration of 25 nM into TLR3+-
HEK293 cells (43 104 cells per 96 wells) with 0.5 ml lipofectamine. Forty-eight
hours after transfection, cells were stimulated and after an additional period of
24 hr levels of IFN-bmRNA were assessed with RT-PCR. Poly(I:C) was added
at 100 ng/ml final concentration, while transfected poly(I:C) was introduced at
10ng/ml. siRNA sequences used for RNA-polymerase III, MAVS, RIG-I, and
STING were obtained from QIAGEN or Invitrogen and are as described
(Ablasser et al., 2009; Ishikawa and Barber, 2008).
Pull-down Assays and Immunoblotting
A total of 3 3 106 HEK293 cells or Tmem173/, Tmem173+/+, Tbk1/
Tnfr1/, and Tnfr1/ BMDMs were lysed with lysis buffer containing
NP-40, dithiothreitol (DTT), phenylmethylsulfonyl fluoride (PMSF), and sodium
orthovanadate (Na3VO4) for 20 min at 4
C. Lysates were spun for debris
removal and then incubated with 1 mg of 30 or 50-biotinylated AT2 (PS) or
AT5 (PD) and streptavidin-agarose beads (50% w/v) for 2 hr. Lysates were
spun for obtaining the bead pellet, washed, and boiled with loading buffer
containing SDS and run on 10% SDS-polyacrylamide gel. Blots were probed
with the STING antibody as described (Ishikawa and Barber, 2008); anti-TBK1
was obtained from Imgenex and anti-b-actin was from Sigma.
ShRNA-Mediated Silencing
The lentiviral shRNA sequences were cloned into pLKO.1 TRC cloning vector
56. The silencing sequence was from the MISSION TRC-Hs 1.0 (Human)
as follows: TRCN0000-123051 for DAI. The production of viral particles
and transduction of target cells were conducted according to the following
protocols (http://www.broad.mit.edu/genome_bio/trc/publicProtocols.html).
Knockdown efficiency was assessed by one-step RT-PCR (Invitrogen)
with the following primers: DAI-F 50-ATCTGCCTGGAGTTACCTTC-30; DAI-R
50-TCTGGATTTCCTGACCTATTG-30 and antibody to DAI (Imgenex).
Statistical Analysis
Differences between groups were analyzed for statistical significance with
Student’s t test. p < 0.05 was considered as statistically significant.ACCESSION NUMBERS
The microarray data are available in the Gene Expression Omnibus (GEO)
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